Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
Cat. No. : CSC-RT2170
Target Gene : STAT1 Host Cell : A549
Size : >1x106 cells/vial Validation : Sequencing
| Cat. No. | CSC-RT2170 |
| Description | This cell is a stable cell line with a homozygous knockout of human STAT1 using CRISPR/Cas9. |
| Target Gene | STAT1 |
| Host Cell | A549 |
| Host Cell Species | Homo sapiens (Human) |
| Size | >1x106 cells/vial |
| Validation | Sequencing |
| Storage | Liquid nirtogen |
| Revival | Rapidly thaw cells in a 37°C water bath. Transfer contents into a tube containing pre-warmed media. Centrifuge cells and seed into a 25 cm2 flask containing pre-warmed media. |
| Mycoplasma | Negative |
| Format | One frozen vial containing millions of cells |
| Storage | Liquid nitrogen |
| Safety Considerations |
The following safety precautions should be observed. 1. Use pipette aids to prevent ingestion and keep aerosols down to a minimum. 2. No eating, drinking or smoking while handling the stable line. 3. Wash hands after handling the stable line and before leaving the lab. 4. Decontaminate work surface with disinfectant or 70% ethanol before and after working with stable cells. 5. All waste should be considered hazardous. 6. Dispose of all liquid waste after each experiment and treat with bleach. |
| Ship | Dry ice |
| Gene Name | STAT1 signal transducer and activator of transcription 1, 91kDa [ Homo sapiens ] |
| Gene Symbol | STAT1 |
| Synonyms | STAT1; signal transducer and activator of transcription 1, 91kDa; signal transducer and activator of transcription 1, 91kD; signal transducer and activator of transcription 1-alpha/beta; ISGF 3; STAT91; transcription factor ISGF 3 components p91/p84; transcription factor ISGF-3 components p91/p84; signal transducer and activator of transcription-1; CANDF7; ISGF-3; DKFZp686B04100; |
| Gene ID | 6772 |
| Uni Prot ID | P42224 |
| m RNA Refseq | BC002704 |
| Chromosome Location | 2q32.2-q32.3 |
| Function | RNA polymerase II core promoter sequence-specific DNA bi |
| Pathway | Adipogenesis, organism-specific biosystem; Antiviral mechanism by IFN-stimulated genes, organism-specific biosystem; B Cell Receptor Signaling Pathway, organism-specific biosystem; CXCR4-mediated signaling events, organism-specific biosystem; Chemokine signaling pathway, organism-specific biosystem; Chemokine signaling pathway, conserved biosystem; Cytokine Signaling in Immune system, organism-specific biosystem; |
| MIM | 600555 |
Zika virus (ZIKV) infection can lead to severe neurological disorders, including neonatal microcephaly and Guillain-Barré syndrome. Long noncoding RNAs (lncRNAs) are byproducts of the transcription process and are thought to influence viral infection. Here, researchers identify a set of human lncRNAs that are upregulated upon ZIKV infection and are dependent on type I interferon (IFN) signaling. Overexpression of the lncRNA ZAP-IT1 results in impaired ZIKV infection. Correspondingly, deficiency of ZAP-IT1 results in enhanced ZIKV infection. Knockout of ZAP-IT1 also results in increased infection with dengue virus (DENV), Japanese encephalitis virus (JEV), or vesicular stomatitis virus (VSV). Thus, these data suggest that the host lncRNA ZAP-IT1, induced by type I IFN signaling, exhibits a strong restrictive effect on ZIKV infection, and even DENV, JEV, and VSV infections, which may facilitate the development of antiviral therapies.
Here, the researchers identified putative binding sites for NF-κB and STAT1, implying a potential association between lncRNA and NF-κB or STAT1 (Figure 1A). They hypothesized that ZIKV might induce the expression of these lncRNAs by activating the IFN signaling pathway. To test this hypothesis, A549 cells were treated with IFN-β. The expression of the four lncRNAs was significantly enhanced after IFN-β treatment (Figure 1B). To further confirm this result, the researchers used MAVS knockout, IFNAR1 knockout, or STAT1 knockout A549 cells, which block the production of IFN and the activation of the IFN signaling pathway. Compared with control cells, the enhanced expression of lncRNAs was blocked after knocking out MAVS, IFNAR1, or STAT1 (Figures 1C and E). These results suggest that LAP3-AS1, LINC21762, VAMP1-AS1, and ZAP-IT1 may belong to interferon-stimulated genes (ISGs) and are specifically induced by activation of IFNs and the IFN pathway.
Figure 1. IFN pathway is involved in the induction of lncRNAs. (Huang Y, et al. 2022)
A: The knockout cell product is validated by PCR amplification and Sanger Sequencing to confirm the mutation at the genomic level. Please find the detailed mutation info in the datasheet.
A: Single clonal cell.
A: No. This knockout cell product is generated using the CRISPR/Cas9 system to induce small insertions or deletions (indels) resulting in frameshift mutations. Although these frameshift mutations typically disrupt the coding gene, there is a possibility that the non-functional transcript may still be transcribed. Consequently, this could potentially yield misleading results when analyzed by RT-qPCR.
A: The cell line should be stored in liquid nitrogen for long-term preservation.
A: For most cases, we often keep at least 2 clones with different frameshift mutations. Please feel free to contact us to check if there are additional available clones.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
Write a review of your use of Biogene products and services in your research. Your review can help your fellow researchers make informed purchasing decisions.